Human Molecular Genetics, 2001, Vol. 10, No. 22 2581-2592
© 2001 Oxford University Press
Familial and sporadic forms of central core disease are associated with mutations in the C-terminal domain of the skeletal muscle ryanodine receptor
1Laboratoire de Biochimie de lADN, CHU Grenoble, Grenoble, France, 2INSERM U523 and Institut de Myologie, Hôpital de la Salpétrière, Paris, France, 3Département de Pédiatrie, CHU Bicêtre, Le Kremlin-Bicêtre, France, 4Département dAnesthésie, Hôpital Robert Debré, Paris, France and 5Laboratoire BECP/DBMS, EA 2943 UJFCEA, Grenoble, France
Central core disease (CCD) is an autosomal dominant congenital myopathy. Diagnosis is based on the presence of cores in skeletal muscles. CCD has been linked to the gene encoding the ryanodine receptor (RYR1) and is considered to be an allelic disease of malignant hyperthermia susceptibility. However, the report of a recessive form of transmission together with a variable clinical presentation has raised the question of the genetic heterogeneity of the disease. Analyzing a panel of 34 families exclusively recruited on the basis of both clinically and morphologically expressed CCD, 12 different mutations of the C-terminal domain of RYR1 have been identified in 16 unrelated families. Morphological analysis of the patients muscles showed different aspects of cores, all of them associated with mutations in the C-terminal region of RYR1. Furthermore, we characterized the presence of neomutations in the RyR1 gene in four families. This indicates that neomutations into the RyR1 gene are not a rare event and must be taken into account for genetic studies of families that present with congenital myopathies type central core disease. Three mutations led to the deletion in frame of amino acids. This is the first report of amino acid deletions in RYR1 associated with CCD. According to a four-transmembrane domain model, the mutations concentrated mostly in the myoplasmic and luminal loops linking, respectively, transmembrane domains T1 and T2 or T3 and T4 of RYR1.
+ To whom correspondence should be addressed at: Laboratoire Biochimie de lADN, EA 2943 UJF, CHU Grenoble BP 217, 38043 Grenoble Cedex, France. Tel: +33 4 76 76 55 73; Fax: +33 4 76 76 58 37; Email: jlunardi@chu-grenoble.fr
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
L. Xu, Y. Wang, N. Yamaguchi, D. A. Pasek, and G. Meissner Single Channel Properties of Heterotetrameric Mutant RyR1 Ion Channels Linked to Core Myopathies J. Biol. Chem., March 7, 2008; 283(10): 6321 - 6329. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Sato, S. Wu, M. C. A. Ibarra, Y. K. Hayashi, H. Fujita, M. Tojo, S. J. Oh, I. Nonaka, S. Noguchi, and I. Nishino Congenital neuromuscular disease with uniform type 1 fiber and RYR1 mutation Neurology, January 8, 2008; 70(2): 114 - 122. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zhou, H. Jungbluth, C. A. Sewry, L. Feng, E. Bertini, K. Bushby, V. Straub, H. Roper, M. R. Rose, M. Brockington, et al. Molecular mechanisms and phenotypic variation in RYR1-related congenital myopathies Brain, August 1, 2007; 130(8): 2024 - 2036. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Fischer, M. Herasse, A. Ferreiro, H. M. Barragan-Campos, J. Chiras, L. Viollet, S. Maugenre, J. -P. Leroy, N. Monnier, J. Lunardi, et al. Muscle imaging in dominant core myopathies linked or unlinked to the ryanodine receptor 1 gene Neurology, December 26, 2006; 67(12): 2217 - 2220. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zhou, N. Yamaguchi, L. Xu, Y. Wang, C. Sewry, H. Jungbluth, F. Zorzato, E. Bertini, F. Muntoni, G. Meissner, et al. Characterization of recessive RYR1 mutations in core myopathies Hum. Mol. Genet., September 15, 2006; 15(18): 2791 - 2803. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Wu, M C. A. Ibarra, M. C. V. Malicdan, K. Murayama, Y. Ichihara, H. Kikuchi, I. Nonaka, S. Noguchi, Y. K. Hayashi, and I. Nishino Central core disease is due to RYR1 mutations in more than 90% of patients Brain, June 1, 2006; 129(6): 1470 - 1480. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Shepherd, F Ellis, J Halsall, P Hopkins, and R Robinson RYR1 mutations in UK central core disease patients: more than just the C-terminal transmembrane region of the RYR1 gene J. Med. Genet., March 1, 2004; 41(3): e33 - 33. [Full Text] [PDF] |
||||
![]() |
K. D. Mathews and S. A. Moore Multiminicore Myopathy, Central Core Disease, Malignant Hyperthermia Susceptibility, and RYR1 Mutations: One Disease With Many Faces? Arch Neurol, January 1, 2004; 61(1): 27 - 29. [Full Text] [PDF] |
||||
![]() |
R M Quinlivan, C R Muller, M Davis, N G Laing, G A Evans, J Dwyer, J Dove, A P Roberts, and C A Sewry Central core disease: clinical, pathological, and genetic features Arch. Dis. Child., December 1, 2003; 88(12): 1051 - 1055. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. B. Romero, N. Monnier, L. Viollet, A. Cortey, M. Chevallay, J. P. Leroy, J. Lunardi, and M. Fardeau Dominant and recessive central core disease associated with RYR1 mutations and fetal akinesia Brain, November 1, 2003; 126(11): 2341 - 2349. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yang, T. A. Ta, I. N. Pessah, and P. D. Allen Functional Defects in Six Ryanodine Receptor Isoform-1 (RyR1) Mutations Associated with Malignant Hyperthermia and Their Impact on Skeletal Excitation-Contraction Coupling J. Biol. Chem., July 3, 2003; 278(28): 25722 - 25730. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Monnier, A. Ferreiro, I. Marty, A. Labarre-Vila, P. Mezin, and J. Lunardi A homozygous splicing mutation causing a depletion of skeletal muscle RYR1 is associated with multi-minicore disease congenital myopathy with ophthalmoplegia Hum. Mol. Genet., May 15, 2003; 12(10): 1171 - 1178. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Zorzato, N. Yamaguchi, L. Xu, G. Meissner, C. R. Muller, P. Pouliquin, F. Muntoni, C. Sewry, T. Girard, and S. Treves Clinical and functional effects of a deletion in a COOH-terminal lumenal loop of the skeletal muscle ryanodine receptor Hum. Mol. Genet., February 15, 2003; 12(4): 379 - 388. [Abstract] [Full Text] [PDF] |
||||






